Hikma Pharmaceutical reported 232M in Selling and Administration Expenses for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
AstraZeneca AZN:LN 2.57B 76M
Bayer BAYN:GR 3.75B 226M
Fresenius FRE:GR 1.4B 134M
Fresenius Medical Care FMS:US 830M 118.48M
Galapagos GLPG:NA 60.95M 15.96M
Genmab GEN:DC 264M 63M
GlaxoSmithKline GSK:LN 2.5B 183M
GRIFOLS GRF:SM 249.86M 7.28M
H. Lundbeck A/S LUN:DC 1.58B 79M
Hikma Pharmaceutical HIK:LN 232M 3M
Merck MRK:GR 1.34B 62M
Orion ORNBV:FH 60.1M 5.5M
Recordati REC:IM 117.42M 4.01M